Sands Capital Alternatives as of Dec. 31, 2025
Portfolio Holdings for Sands Capital Alternatives
Sands Capital Alternatives holds 20 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Klaviyo Com Ser A (KVYO) | 22.9 | $119M | 3.6M | 32.47 | |
| Nu Hldgs Ord Shs Cl A (NU) | 22.2 | $115M | 6.9M | 16.74 | |
| Beta Bionics (BBNX) | 21.0 | $109M | 3.6M | 30.47 | |
| Inhibikase Therapeutics Com New (IKT) | 5.1 | $27M | 13M | 2.05 | |
| Doordash Cl A (DASH) | 4.2 | $22M | 96k | 226.48 | |
| Coupang Cl A (CPNG) | 4.0 | $21M | 870k | 23.59 | |
| Samsara Com Cl A (IOT) | 3.2 | $17M | 466k | 35.45 | |
| Datadog Cl A Com (DDOG) | 2.3 | $12M | 86k | 135.99 | |
| Toast Cl A (TOST) | 2.1 | $11M | 302k | 35.51 | |
| Bioage Labs (BIOA) | 2.0 | $10M | 786k | 13.23 | |
| Monday SHS (MNDY) | 1.9 | $10M | 68k | 147.56 | |
| Servicetitan Shs Cl A (TTAN) | 1.8 | $9.6M | 90k | 106.50 | |
| 10x Genomics Cl A Com (TXG) | 1.5 | $7.9M | 482k | 16.31 | |
| Acumen Pharmaceuticals (ABOS) | 1.4 | $7.2M | 3.4M | 2.11 | |
| Tarsus Pharmaceuticals (TARS) | 1.3 | $7.0M | 85k | 81.88 | |
| Acrivon Therapeutics Common Stock (ACRV) | 1.0 | $5.1M | 2.1M | 2.41 | |
| Snowflake Com Shs (SNOW) | 0.9 | $4.4M | 20k | 219.36 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.8 | $4.0M | 725k | 5.50 | |
| Candel Therapeutics (CADL) | 0.4 | $2.3M | 406k | 5.65 | |
| Figma Class A Com Stk (FIG) | 0.1 | $683k | 18k | 37.37 |
